Advances in the Prevention and Treatment of Cardiovascular Diseases: What We Addressed and What We Still Need to Address
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425).
Deadline for manuscript submissions: 30 June 2026 | Viewed by 11
Special Issue Editors
Interests: coronary angiography; percutaneous coronary intervention; percutaneous structural intervention
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent years, many pharmacological and interventional treatments have been introduced to treat various cardiovascular diseases (CVDs). The prognosis of each individual disease has been improved. However, cardiovascular diseases still remain the first cause of death in developed countries. Thus, there are still many needs to be addressed. Might prevention be the future most important area of reserch for this spectrum of disease?
The aim of this Special Issue is to collect submissions focusing on the latest advances in the prevention and treatment of cardiovascular diseases. In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
Advanced treatment, including pharmacological and non-pharmacological interventions.
The use of new technologies in diagnosis and management.
The role of lifestyle modifications in prevention and treatment.
The impact of comorbidities on prevention and treatment.
The challenges and future directions in prevention and treatment .
Coronary artery disease.
Coronary angiography.
Percutaneous coronary intervention.
Percutaneous structural intervention.
Left atrial appendage closure.
Transcatheter aortic valve implantation (TAVI).
Dr. Alessandro Durante
Guest Editor
Dr. Alessandro Mazzapicchi
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
